BCR and prostate carcinoma: To comprehensively evaluate the prognostic significance of PRDXs in prostate cancer, we generated BCR‐free survival curves for PRDXs across 7 databases (TCGA, CancerMap, DKFZ2018, GSE54460, GSE70769, Cambridge and GSE116918).